Evan T. Hall, MD, MPhil

Seattle Cancer Care Alliance
Assistant Professor
University of Washington School of Medicine
Assistant Professor, Clinical Research Division
Fred Hutchinson Cancer Research Center
Medical Oncology
“I don’t believe in a one-size-fits-all approach to medicine; my goal is to work with you to find the best treatment for you.”
— Dr. Hall
Has cancer touched your life personally?

Both of my parents have been diagnosed with cancer. As I have watched them navigate the medical system, I have realized just how disruptive the whole process can be for patients and family members, even when treatments are successful. There can be a lot of anxiety, particularly in the time between the diagnosis and the formation of a treatment plan. Our goal at SCCA is to organize the next steps as efficiently as possible, so patients feel less adrift as they make sense of what is happening and what their treatment may entail.

How do you like to work with patients?

My philosophy of practicing medicine is informed greatly by the question: What’s causing you the most distress, and how can I help make that better? Often, it’s about more than just alleviating physical symptoms or treating the cancer. Are you able to pursue the activities in life that bring you joy while undergoing treatment? Maybe that’s playing with your grandkids, going to concerts or perfecting your golf swing. The more that I know about the fabric of your life, the better guidance I can offer and the better decisions we can ultimately make together.

Provider background

Specialty: Medical Oncology

Skin cancer, kidney cancer

I am a medical oncologist who specializes in treating skin cancers (including melanoma) and kidney cancer. The treatment of these cancers has changed significantly over the past decade. Now they are commonly treated with novel therapies, such as immunotherapy and targeted therapy, instead of traditional chemotherapy. My research focuses on how to measure and improve quality of life for patients with cancer. For example, one study I led found that the instruments we currently use to analyze how patients feel during cancer treatment do not account for the unique side effects of immunotherapy. We need to develop new tools to better measure patients’ quality of life while receiving this type of treatment. My other areas of interest include physician-patient communication, the health economics of cancer and the benefits of novel modes of patient and caregiver social support, such as online communities.

Diseases treated

Education, experience and certifications
Undergraduate Degree
Pomona College
Medical Degree
University of California-San Diego
Stanford University School of Medicine, Internal Medicine
Stanford University School of Medicine, Hematology-Oncology
Board Certification
Internal Medicine, 2015, American Board of Internal Medicine
Master of Philosophy, University of Cambridge, United Kingdom
Jonathan K. Cho, MD, and Cora Y. Cho Endowed Merit Award

Sponsored by the Conquer Cancer Foundation, this award supported Dr. Hall in the presentation of his research at the annual meeting of the American Society of Clinical Oncology (ASCO) in 2019. His research examined the economic impacts of different immunotherapy dosing strategies.

Conquer Cancer Foundation Merit Award

The Merit Award supported the presentation of Dr. Hall’s research at the 2017 ASCO annual meeting. His work explored the clinical outcomes of patients with inherited cancer mutations.


Clinical trials

We make promising new treatments available to you through studies called clinical trials led by SCCA doctors. Many of these trials at SCCA have led to FDA-approved treatments and have improved standards of care globally. Together, you and your doctor can decide if a study is right for you.

Study ID:
Complete title
Repository of Data and Specimens for Uveal Melanoma Research
Study ID:
Study to Compare Adjuvant Immunotherapy of Bempegaldesleukin Combined With Nivolumab Versus Nivolumab After Complete Resection of Melanoma in Patients at High Risk for Recurrence (PIVOT-12)
Complete title
A Phase 3, Randomized, Open-label Study to Compare Adjuvant Immunotherapy of Bempegaldesleukin Combined with Nivolumab Versus Nivolumab After Complete Resection of Melanoma in Patients at High Risk for Recurrence (PIVOT-12)
Study ID:
Complete title
Establishment of a National Biorepository to Advance Studies of Immune-Related Adverse Events


Many of our SCCA physicians conduct ongoing research to improve standards of patient care. Their work is evaluated by other physicians and selected for publication to the United States National Library of Medicine, the largest medical library in the world. See scientific papers this SCCA provider has written.


SCCA providers are often asked to give their medical expertise for press and news publications. Read articles by or about this SCCA provider.

6 Steps to Take After a Kidney Cancer Diagnosis

SCCA's Evan Hall, MD, talked about how to prepare for kidney cancer management and treatment after diagnosis.

Your care team

At SCCA, you receive care from a team of providers with extensive experience in your disease. Your team includes doctors, a team coordinator, a registered nurse, an advanced practice provider and others, based on your needs. You also have access to experts like nutritionists, social workers, acupuncturists, psychiatrists and more who specialize in supporting people with cancer or blood disorders.
Registered nurse (RN)
Registered nurse (RN)
Your nurse manages your care alongside your physician and assists with care procedures and treatments.
Team coordinator (TC)
Team coordinator (TC)
Your team coordinator works closely with you and your physician and serves as your scheduler.


SCCA accepts most national private health insurance plans as well as Medicare. We also accept Medicaid for people from Washington, Alaska, Montana and Idaho. We are working to ensure that everyone, no matter what their financial situation, has access to the care they need.

For providers